Ketamine wafer could offer faster relief for depression and pain
NCT ID NCT07691372
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This study tests a new form of ketamine—a wafer that dissolves under the tongue—in healthy adults. Participants receive three different single doses (25 mg, 50 mg, and 75 mg) in a fixed order, with time between doses to clear the drug. Researchers measure how much ketamine enters the blood, how fast it is eliminated, and any side effects. The goal is to understand the drug's behavior in the body and its safety before testing in patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Wafermine™ (ketamine sublingual wafer)
- What this could lead to
- If successful, this could lead to a new way to deliver ketamine for conditions like depression or pain, with faster absorption and fewer side effects than current methods.
- What could go wrong
- This is an early Phase 1 study in only 14 healthy people, so results may not apply to patients. Ketamine can cause side effects like dizziness, nausea, or dissociation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Q-Pharm Pty Ltd.
Brisbane, Queensland, 4006, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver function may change how D-2570 works in the body
- Cannabis-Based drug BRC-002 enters first human safety trials
- Scientists track coke zero sweetener through the body in 24-Hour urine study
- New Alzheimer's drug candidate enters first human safety tests
- Zapping a deep belly muscle may give CrossFitters a squat edge
- Could a Fiber-Fortified biscuit help tame blood sugar spikes?